With the advent of a specific biological therapy for ALS there is an increasing imperative for early diagnosis. As new, more effective therapies become available, this will become more important. It is intuitively probable that early therapy will prevent disability in this otherwise relentlessly progressive disorder. The difficulties posed by this need for early diagnosis in clinical practice are discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0022-510x(98)00215-9 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!